Regulations.gov document
Determination That Chirocaine (Levobupivacaine) Injection, 2.5 Milligrams…
Notice · FDA-2022-P-3293 · posted May 25, 2023
Key facts
| Document ID | FDA-2022-P-3293-0003 |
|---|---|
| Title | Determination That Chirocaine (Levobupivacaine) Injection, 2.5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials, 5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials and 7.5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2022-P-3293 |
| Posted | May 25, 2023 |
| Federal Register citation | 88 FR 33888 |
| FR document number | 2023-11162 |
| Comment period opens | May 25, 2023 |
| Effective date | May 25, 2023 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: